{"id":86936,"date":"2025-08-23T07:40:10","date_gmt":"2025-08-23T07:40:10","guid":{"rendered":"https:\/\/www.newsbeep.com\/uk\/86936\/"},"modified":"2025-08-23T07:40:10","modified_gmt":"2025-08-23T07:40:10","slug":"ionis-gets-approval-for-preventing-attacks-in-rare-and-genetic-hae","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/uk\/86936\/","title":{"rendered":"Ionis gets approval for preventing attacks in rare and genetic HAE"},"content":{"rendered":"<p>In Ionis Pharmaceuticals Inc.\u2019s second U.S. FDA approval in under a year, the agency approved Dawnzera (donidalorsen) as a prophylactic therapy in the rare and genetic disease hereditary angioedema (HAE). The approval came as scheduled as the NDA had a PDUFA date of Aug. 21. Dawnzera now joins a market with previously approved drugs for the rare, genetic, life-threatening condition, as well as other companies with HAE drugs in development.<\/p>\n<p><a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/84-bioworld\" rel=\"nofollow noopener\" target=\"_blank\">BioWorld<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/402-regulatory\" rel=\"nofollow noopener\" target=\"_blank\">Regulatory<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/242-dermatologic\" rel=\"nofollow noopener\" target=\"_blank\">Dermatologic<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/271-antisense\" rel=\"nofollow noopener\" target=\"_blank\">Antisense<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/433-fda\" rel=\"nofollow noopener\" target=\"_blank\">FDA<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"In Ionis Pharmaceuticals Inc.\u2019s second U.S. FDA approval in under a year, the agency approved Dawnzera (donidalorsen) as&hellip;\n","protected":false},"author":2,"featured_media":86937,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25],"tags":[43727,43720,43725,43726,43724,7552,12346,916,43722,43721,43723,20202,29672,90,56,54,55],"class_list":{"0":"post-86936","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetics","8":"tag-antisense","9":"tag-bioworld","10":"tag-dawnzera","11":"tag-dermatologic","12":"tag-donidalorsen","13":"tag-fda","14":"tag-genetic-diseases","15":"tag-genetics","16":"tag-hereditary-angioedema","17":"tag-ionis-pharmaceuticals-inc","18":"tag-prophylactic-therapies","19":"tag-rare-disease","20":"tag-regulatory","21":"tag-science","22":"tag-uk","23":"tag-united-kingdom","24":"tag-unitedkingdom"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/86936","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/comments?post=86936"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/86936\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media\/86937"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media?parent=86936"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/categories?post=86936"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/tags?post=86936"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}